Browsing by Author Qiu, Lugui

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 28 to 30 of 30 < previous 
Issue DateTitleAuthor(s)
2014Transiently Elevated AST/LDH Are Associated with Clinical Response to Recombinant Circularly Permuted TRAIL (CPT) Plus Thalidomide in Patients with Relapsed and/or Refractory Multiple MyelomaChen, Wenming; Wei, Peng; Yang, Shifang; Zheng, Xiangjun; Qiu, Lugui; Hou, Jian; Zhang, Xuejun; Wang, Zhao; Ke, Xiaoyan; Pan, Ling; Pang, Hongyan
Apr-2022A two-part, single-arm, multicentre, phase I study of zanubrutinib, a selective Bruton tyrosine kinase inhibitor, in Chinese patients with relapsed/refractory B-cell malignanciesSong, Yuqin; Sun, Mingyuan; Qi, Junyuan; Xu, Wei; Zhou, Jianfeng; Li, Dengju; Li, Jianyong; Qiu, Lugui; Du, Chenmu; Guo, Haiyi; Huang, Jane; Tang, Zhiyu; Ou, Ying; Wu, Binghao; Yu, Yiling; Zhu, Jun
Jul-2022Zanubrutinib Monotherapy for Naive and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three StudiesXu, Wei; Yang, Shenmiao; Tam, Constantine S.; Seymour, John F.; Zhou, Keshu; Opat, Stephen; Qiu, Lugui; Sun, Mingyuan; Wang, Tingyu; Trotman, Judith; Pan, Ling; Gao, Sujun; Zhou, Jianfeng; Zhou, Daobin; Zhu, Jun; Song, Yuqin; Hu, Jianda; Feng, Ru; Huang, Haiwen; Su, Dan; Shi, Miao; Li, Jianyong
Showing results 28 to 30 of 30 < previous